Evidence map›Paper›PMID 42403440›Full record

ArticleAmerican journal of preventive cardiology2026

Impact of air pollution exposure on chronic kidney disease and type 2 diabetes: A FIDELITY analysis.

Sadeer Al-Kindi, Zhuo Chen, Jean-Eudes Dazard, Youssef M K Farag, Gerasimos Filippatos, Peter Rossing, Katja Rohwedder, Pedro Rafael Vieira de Oliveira Salerno, Charlie Scott, Zihe Zheng and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sadeer Al-KindiCenter for CV Computational & Precision Health, Academy of Translational Research, Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist, Houston, TX, USA.
Zhuo ChenUniversity Hospitals Harrington Heart & Vascular Institute, Cleveland, OH, USA.
Jean-Eudes DazardDepartment of Medicine, Cardiovascular Research Institute, Case Western Reserve University, Cleveland, OH, USA.
Youssef M K FaragPostgraduate Medical Education, Harvard Medical School, Boston, MA, USA.
Gerasimos FilippatosNational and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece.
Peter RossingSteno Diabetes Center Copenhagen, Copenhagen, Denmark.
Katja RohwedderCardio-Renal Medical Affairs Department, Bayer AG, Berlin, Germany.
Pedro Rafael Vieira de Oliveira SalernoDepartment of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, Queens, NY, USA.
Charlie ScottClinical Statistics and Analytics, Bayer Corporation, USA.
Zihe ZhengMedical Affairs Cardio-Renal Division, Bayer U.S. LLC, Whippany, NJ, USA.
Sanjay RajagopalanDepartment of Internal Medicine and Biomedical Engineering, University Hospitals Harrington Heart & Vascular Institute, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA.
FIDELIO-DKD and FIGARO-DKD Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Exposure to particulate matter air pollution ≤2.5 µm (PM Methods: Patients with CKD and T2D on optimized renin-angiotensin system blockade were randomized 1:1 to finerenone or placebo. Key outcomes included composite CV outcomes (CV death, nonfatal myocardial infarction, nonfatal stroke, hospitalization for heart failure); composite kidney outcomes (kidney failure, sustained ≥57 % decrease in eGFR, kidney-related death); combined composite CV and kidney outcomes; and safety. Outcomes were stratified by PM Results: Median PM Conclusions: Increased PM

Indexed as

Air pollutionChronic kidney diseaseFinerenonePM2.5 exposureType 2 diabetes

Identifiers

PMID42403440
PMCPMC13329385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.